BridgeMD
New treatment option for Biofeedback
Official title Effects of Myoelectric Biofeedback on Upper Limb Function in Post-stroke Patients
ClinicalTrials.gov ID: NCT06443008
What this study is testing
- What it's testing
- The purpose of this clinical trial is to investigate the effect of myoelectric biofeedback therapy on upper limb function in elderly patients with cerebral infarction, and to analyze the adjustment of stroke condition and quality of life.The main questions it aims to answer are: 1. Does myoelectric biofeedback therapy promote the restoration of upper limb function in elderly patients with cerebral infarction?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 80
You may be able to join if
- Subject volunteered to participate in the experiment and signed informed consent
- Age ≥ 65 years old, no gender limit;
- Diagnosis of stroke patients;
- No other major cardiovascular diseases
You likely can't join if
- Subject's poor compliance
- people with skin allergies
- Those who do not meet the criteria for diagnosis and inclusion;
- People with severe consciousness disorders, severe dementia, speech disorders, etc. who are unable to communicate and describe the disease;
- can not cooperate as required, poor compliance;
- participants in other clinical trials;
The study team makes the final eligibility decision.
Where it's taking place
- Yiwu, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yiwu, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.